Gamma-cyclodextrin and how it changes berberine absorption
Treatments studied
This Phase 1 study checks how gamma-cyclodextrin affects how the body absorbs berberine. It’s designed to understand whether berberine levels in the blood change when taken with this ingredient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy volunteer based on your medical history, exam, and lab tests
- Be willing to stay overnight at the study site for the study’s duration
- Sign an informed consent form
- Have a BMI of 35 or less (not overweight by their definition)
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a natural supplement called berberine changes the bacteria in your gut. You'll be compared to healthy people without polyps to see if berberine helps prevent polyps from coming back.
This study tests if a berberine-based supplement can help regulate blood sugar and metabolism in people who are overweight and have slightly elevated blood sugar (prediabetes). Participants will take the supplement and maintain their normal lifestyle.
This trial tests whether berberine, a natural supplement, can lower cholesterol and fats in the blood specifically in Chinese women. It aims to see if berberine works differently for women than for men.
This study tests an herbal supplement (berberine) in people with slightly high blood sugar (prediabetes). The goal is to find the best dose.
This trial tests whether berberine, a natural plant compound, can help reverse precancerous changes in the stomach lining. If you have a certain type of stomach cell change (called gastric intestinal metaplasia) and do not have an H. pylori infection, this study might be an option.
This trial studies whether berberine changes how strongly your platelets “stick together” after a coronary stent. It may help reduce risk related to clotting while you continue standard heart medicines (aspirin and clopidogrel).
Hear when a new Drug Absorption trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.